IPO News Archive

Cathay Industrial Biotech postpones IPO

8/8/11


Cathay Industrial Biotech, a Chinese producer of biobutanol and LCDAs used in chemical and fuel markets, postponed its IPO due to poor market conditions, according to a press release from venture backer HBM BioVentures. The press release stated that alternative financing methods were being implemented. The Shanghai, China-based company was founded in 1997 and booked $143.6 million in sales for the 12 months ended 3/31/11. Morgan Stanley, Deutsche Bank Securities, and Jefferies were set to be the underwriters on the deal.
Keywords/Tickers: CBIO
Source: www.RenaissanceCapital.com
blog comments powered by Disqus
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the Global IPO Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in Global IPO Fund
About Fund Prospectus Invest